Clinical trial
The Efficacy and Safety of Botulinum Toxin for the Treatment of Trigeminal Neuralgia: Comparison of Two Different Treatment Methods
NCT03331913 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Botulinum Toxin for the Treatment of Trigeminal Neuralgia: Comparison of Two Different Treatment Methods
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 7, 2017
- Completion date
- March 31, 2019
- Enrollment
- 150 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.